Home
Phyllis Shelton About Us Contact Us LTC Store

FDA Approves New Drug for Alzheimer's

WASHINGTON, DC -- 10/20/2003 -- (Eli Digital) There's a new treatment option for people suffering from advanced Alzheimer's disease. [Michael, link to rest of article here]

The U.S. Food and Drug Administration on Friday gave its approval to memantine, which has long been sold in Europe. "The approval of memantine is good news for Alzheimer's disease patients," said FDA Commissioner Dr. Mark McClellan. "This is the first drug shown to have an effect on the symptoms of moderate to severe Alzheimer's disease, and shows a low incidence of minor side effects."

Forest Laboratories will sell the drug in the United States under the brand name Namenda. For more details on the FDA's action, click here.
(Source: www.snalfnews.com)

Product Catalog
Seminars
Agent Services
Consumer News
LTCiTraining.com
Articles


  AGENT QUESTIONS
  ----------------------------
   USEFUL LINKS
  ----------------------------

   LTCI REPORTS
  ----------------------------
   LTCI PARTNERSHIP
  ----------------------------
   TESTIMONIALS
  ----------------------------

FAQ Home
Tech Support

 

 

 

E-mail this page
   
© 2015 LTC Consultants. All Rights Reserved.